Analyst Consensus ?
ConsensusHold35 ratings
Bullish1440.0%
Neutral1954.3%
Bearish25.7%
FN2 Earnings Intelligence
Baxter International Inc. (BAX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Jul 28, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 28, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 27, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Citigroup | Sell | Neutral | Downgrade | May 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 4, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Dec 2, 2025 |
| Argus Research | Hold | Buy | Downgrade | Oct 31, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 1, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Feb 21, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Mar 5, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Jul 31, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 28, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 10, 2023 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 5, 2023 |
| Jefferies | Hold | Hold | Maintain | Oct 12, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 5, 2021 |
| Piper Sandler | Neutral | Overweight | Downgrade | Jan 29, 2021 |
| Oppenheimer | Outperform | Outperform | Maintain | Jun 24, 2020 |
| SVB Leerink | Outperform | Outperform | Maintain | May 1, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 6, 2020 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 8, 2018 |
| Argus | Buy | Hold | Upgrade | Nov 2, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Nov 1, 2018 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 1, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Bank of America | Buy | Buy | Maintain | May 22, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 30, 2018 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jun 30, 2017 |
| CL King | Buy | Neutral | Upgrade | Sep 4, 2013 |
| Mizuho | Neutral | Buy | Downgrade | Nov 27, 2012 |
| Dougherty & Co. | Neutral | Neutral | Maintain | Mar 5, 2012 |
| Dougherty | Neutral | Neutral | Maintain | Mar 5, 2012 |
| Standpoint Research | Hold | Buy | Downgrade | Feb 16, 2012 |
Upside is calculated against the persisted current price $26.18. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $25 | $24.49 | -4.5% | Jul 28, 2026 |
| Stifel Nicolaus | Rick Wise | $24 | $23.34 | -8.3% | Jul 28, 2026 |
| Goldman Sachs | Analyst unavailable | $21 | $21.8 | -19.8% | Jul 15, 2026 |
| Evercore ISI | Vijay Kumar | $24 | $22.22 | -8.3% | Jul 6, 2026 |
| Barclays | Analyst unavailable | $27 | $17.21 | +3.2% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $17 | $20.54 | -35.1% | Feb 17, 2026 |
| UBS | Danielle Antalffy | $19 | $19.79 | -27.4% | Feb 16, 2026 |
| Deutsche Bank | Analyst unavailable | $20 | $19.23 | -23.6% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $25 | $18.71 | -4.5% | Feb 13, 2026 |
| Jefferies | Analyst unavailable | $19 | $18.71 | -27.4% | Feb 12, 2026 |
| Stifel Nicolaus | Analyst unavailable | $20 | $18.71 | -23.6% | Feb 12, 2026 |
| Barclays | Matt Miksic | $30 | $20.69 | +14.6% | Jan 9, 2026 |
| Goldman Sachs | Analyst unavailable | $23 | $20.69 | -12.1% | Jan 9, 2026 |
| Evercore ISI | Vijay Kumar | $23 | $20.02 | -12.1% | Jan 5, 2026 |
| Morgan Stanley | Patrick Wood | $15 | $19.08 | -42.7% | Dec 2, 2025 |
| Goldman Sachs | David Roman | $22 | $18.81 | -16.0% | Oct 31, 2025 |
| Stifel Nicolaus | Analyst unavailable | $22 | $19.18 | -16.0% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $36 | $22.44 | +37.5% | Aug 4, 2025 |
| UBS | Analyst unavailable | $24 | $22.44 | -8.3% | Aug 4, 2025 |
| Evercore ISI | Vijay Kumar | $42 | $29.26 | +60.5% | Jan 2, 2025 |
| Bank of America Securities | Travis Steed | $45 | $36.32 | +71.9% | Oct 4, 2024 |
| Jefferies | Matthew Taylor | $42 | $36.92 | +60.5% | Aug 6, 2024 |
| Morgan Stanley | Patrick Wood | $30 | $35.32 | +14.6% | Jul 15, 2024 |
| Goldman Sachs | David Roman | $36 | $33.31 | +37.5% | Jun 12, 2024 |
| UBS | Danielle Antalffy | $40 | $36.91 | +52.8% | May 3, 2024 |
| Jefferies | Matthew Taylor | $43 | $36.89 | +64.3% | May 2, 2024 |
| Stifel Nicolaus | Rick Wise | $44 | $36.72 | +68.1% | May 2, 2024 |
| Barclays | Matt Miksic | $54 | $45.26 | +106.3% | Jul 31, 2023 |
| Jefferies | Philippe Houchois | $85 | $47.01 | +224.7% | Jul 31, 2023 |
| Citigroup | Joanne Wuensch | $44 | $39.71 | +68.1% | Mar 27, 2023 |
| Raymond James | Analyst unavailable | $85 | $70.35 | +224.7% | Apr 29, 2022 |
| Wells Fargo | Analyst unavailable | $90 | $70.2 | +243.8% | Apr 29, 2022 |
| Bank of America Securities | Travis Steed | $100 | $85.19 | +282.0% | Mar 3, 2022 |
| Morgan Stanley | David Lewis | $105 | $82.35 | +301.1% | Feb 18, 2022 |
| Goldman Sachs | Amit Hazan | $91 | $85.91 | +247.7% | Feb 13, 2022 |
| Citigroup | Joanne Wuensch | $101 | $87.16 | +285.9% | Jan 7, 2022 |
| J.P. Morgan | Robbie Marcus | $95 | $83.36 | +262.9% | Dec 17, 2021 |
| Cowen & Co. | Josh Jennings | $98 | $82.93 | +274.4% | Dec 13, 2021 |
| Piper Sandler | Matthew O'Brien | $82 | $80.49 | +213.3% | Sep 2, 2021 |
Track every rating change on BAX the moment it posts. Free to start.
Start free